Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05387863 · ClinicalTrials.gov registry record · NA
Decision Aid (DA) for Renal Patients
A NA study of Renal Cancer and Kidney Tumor, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05387863: Recruiting NA study of Renal Cancer and Kidney Tumor, sponsored by NYU Langone Health.
NCT05387863 is a NA study of Renal Cancer and Kidney Tumor that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 40 participants, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05387863, a NA study of Renal Cancer and Kidney Tumor, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
Primary Outcome
Via a survey, patients will be asked general questions about kidney masses and their treatments. There are 10 questions, each scored as correct or incorrect (0 or 1), and the last question has 3 sub-components each scored 0-1. The total range of score is 0-10; a score of 10 indicates strongest knowledge on kidney masses/treatments.
Conditions Studied
Interventions
- OTHER Decision Aid (DA) Web Tool
- OTHER Institutional Pamphlet
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05387863 shows while recruiting
NCT05387863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Renal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Decision Aid (DA) Web Tool is the first listed.
NCT05387863 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05387863 about?
NCT05387863 is a clinical study titled "Decision Aid (DA) for Renal Patients". The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized bene...
What is the current status of trial NCT05387863?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-12. Estimated completion is 2026-09.
What conditions does trial NCT05387863 study?
This clinical trial studies the following conditions: Renal Cancer, Kidney Tumor.
What interventions are being tested in trial NCT05387863?
The interventions under investigation include: Decision Aid (DA) Web Tool (OTHER), Institutional Pamphlet (OTHER).
Who is sponsoring clinical trial NCT05387863?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05387863 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05387863's enrollment target sits among peer trials
40 23rd of 29 higher than 6 of 29 other Renal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Advanced Diffusion Imaging in Renal Cancer Patients
RECRUITING · NA
-
Video Education With Result Dependent dIsclosure
RECRUITING · NA
-
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
ACTIVE NOT RECRUITING · NA
-
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
ACTIVE NOT RECRUITING · NA
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI